Follow
Eman Dokla
Eman Dokla
Faculty of Pharmacy, Ain Shams University
Verified email at pharma.asu.edu.eg - Homepage
Title
Cited by
Cited by
Year
Penicillin binding protein 2a: An overview and a medicinal chemistry perspective
MAW Shalaby, EME Dokla, RAT Serya, KAM Abouzid
European journal of medicinal chemistry 199, 112312, 2020
852020
Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria
EME Dokla, NS Abutaleb, SN Milik, D Li, K El-Baz, MAW Shalaby, ...
European Journal of Medicinal Chemistry 186, 111850, 2020
542020
1, 2, 4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC
EME Dokla, CS Fang, KAM Abouzid, CS Chen
European Journal of Medicinal Chemistry 182, 111607, 2019
312019
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia
EME Dokla, AK Abdel-Aziz, SN Milik, MJ McPhillie, S Minucci, ...
Bioorganic & Medicinal Chemistry 56, 116596, 2022
112022
SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria
EME Dokla, NS Abutaleb, SN Milik, EAEA Kandil, OM Qassem, ...
European Journal of Medicinal Chemistry 247, 115040, 2023
102023
Applying ligands profiling using multiple extended electron distribution based field templates and feature trees similarity searching in the discovery of new generation of urea …
EM Dokla, AH Mahmoud, MSA Elsayed, AH El-Khatib, MW Linscheid, ...
Plos one 7 (11), e49284, 2012
102012
A 5′ AMP‐activated protein kinase enzyme activator, compound 59, induces autophagy and apoptosis in human oral squamous cell carcinoma
JR Weng, EME Dokla, LY Bai, CS Chen, SJ Chiu, TM Shieh
Basic & Clinical Pharmacology & Toxicology 123 (1), 21-29, 2018
92018
Targeting YAP degradation by a novel 1, 2, 4-oxadiazole derivative via restoration of the function of the Hippo pathway
EME Dokla, CS Fang, PC Chu, CS Chang, KAM Abouzid, CS Chen
ACS Medicinal Chemistry Letters 11 (4), 426-432, 2020
72020
Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: Design, synthesis, and biological evaluation
MAW Shalaby, EME Dokla, RAT Serya, KAM Abouzid
Archives of Pharmaceutical Sciences Ain Shams University 3 (2), 228-245, 2019
72019
Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer
EME Dokla, AK Abdel-Aziz, SN Milik, AH Mahmoud, MK Saadeldin, ...
Bioorganic Chemistry 117, 105451, 2021
62021
Discovery of EMD37, a 1, 2, 4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity
AK Abdel-Aziz, EME Dokla, KAM Abouzid, S Minucci
Biochemical Pharmacology 206, 115316, 2022
52022
Development of potent adenosine monophosphate activated protein kinase (AMPK) activators
EME Dokla, CS Fang, PT Lai, SK Kulp, RAT Serya, NSM Ismail, ...
ChemMedChem 10 (11), 1915-1923, 2015
42015
FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: an updated comprehensive review
AK Abdel-Aziz, EME Dokla, MK Saadeldin
Critical Reviews in Oncology/Hematology, 104139, 2023
32023
Induction of apoptosis using ATN as a novel Yes‐associated protein inhibitor in human oral squamous cell carcinoma cells
PC Chu, EME Dokla, JL Hu, JR Weng
Environmental Toxicology 37 (6), 1404-1412, 2022
32022
Ligand design, synthesis and biological anti-HCV evaluations for genotypes 1b and 4a of certain 4-(3-& 4-[3-(3, 5-dibromo-4-hydroxyphenyl)-propylamino] phenyl) butyric acids …
MAH Ismail, KAM Abouzid, NS Mohamed, EME Dokla
Journal of Enzyme Inhibition and Medicinal Chemistry 28 (6), 1274-1290, 2013
32013
Nanoemulgel formulation of a benzimidazole derivative for wound healing
EME Dokla, RI El-Gogary, NM Abd-Elsaid, M Gad, RK Abd-Elhalim, ...
Journal of Drug Delivery Science and Technology 90, 105121, 2023
12023
Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells
SWA Helmy, AK Abdel-Aziz, EME Dokla, TE Ahmed, Y Hatem, ...
European Journal of Medicinal Chemistry, 116255, 2024
2024
AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase
N Alaa El-Deen, EME Dokla, MY Jaballah, K Abouzid, RA Serya
Egyptian Journal of Chemistry, 2023
2023
A 5′ AMP-Activated Protein Kinase Enzyme Activator, Compound 59, Induces Autophagy and Apoptosis in Human Oral
JR Weng, EME Dokla, LY Bai, CS Chen, SJ Chiu, TM Shieh
of BCPT (former Nordic Pharmacological Society) and Editors of the products …, 1865
1865
The system can't perform the operation now. Try again later.
Articles 1–19